The First Affiliated Hospital Of Henan University Of Science And Technology
Clinical trials sponsored by The First Affiliated Hospital Of Henan University Of Science And Technology, explained in plain language.
-
New combo aims to save esophagus in advanced cancer patients
Disease control Recruiting nowThis study tests whether combining the immunotherapy drug camrelizumab with chemotherapy and radiation can shrink advanced esophageal cancer enough to avoid surgery. About 164 patients with stage II to IVa esophageal squamous cell carcinoma will receive one of two drug combinatio…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
RNA technology takes on diabetes: first human trial of exenatide nanoparticle injection
Disease control Recruiting nowThis early-phase trial is testing a single dose of a new type of exenatide injection (CR059) in 9 Chinese adults with type 2 diabetes. The exenatide is delivered using circular RNA wrapped in lipid nanoparticles, a technology similar to some vaccines. The main goal is to check sa…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC